Moxifloxacin Impurity 71
|
莫西沙星雜質(zhì)71
|
|
Moxifloxacin Impurity 14
|
莫西沙星雜質(zhì)14
|
|
Esmolol Isopropyl Amide
|
艾司洛爾異丙胺雜質(zhì)
|
83356-59-6
|
Vonoprazan Impurity 92
|
沃諾拉贊雜質(zhì)92
|
|
21-Methoxy Triamcinolone Acetonide
|
21-甲氧基曲安奈德
|
161740-70-1
|
Betamethasone Valerate EP Impurity D
|
倍他米松戊酸酯EP雜質(zhì)D
|
|
D-Homo A Derivative of Dexamethasone
|
D-人地塞米松的A衍生物
|
|
Fluticasone Impurity 8
|
氟替卡松雜質(zhì)8
|
|
Moxifloxacin Impurity 1
|
莫西沙星雜質(zhì)1
|
|
Parecoxib Impurity 12
|
帕瑞昔布雜質(zhì)12
|
|
Sorafenib Related Compound
|
索拉非尼相關(guān)化合物
|
2206827-14-5
|
Lurasidone Impurity 32 HCl
|
魯拉西酮雜質(zhì)32鹽酸
|
|
Lacosamide Impurity 10
|
拉科酰胺雜質(zhì)10對照品
|
|
4-Hydroxy Ipratropium Bromide
|
4-羥基異丙托溴銨
|
|
Ilaprazole Impurity 16
|
艾普拉唑雜質(zhì)16
|
|
Moxifloxacin Impurity 65
|
莫西沙星雜質(zhì)65
|
172602-81-2
|
Vonoprazan Impurity 60
|
沃諾拉贊雜質(zhì) 60
|
|
Betamethasone Impurity 49
|
倍他米松雜質(zhì)49
|
1184871-61-1
|
Bisoprolol EP Impurity C DiHCl
|
比索洛爾EP雜質(zhì)C二鹽酸
|
1225195-70-9
|
Betamethasone 9,11-Alpha-Epoxide
|
倍他米松9,11-α-環(huán)氧乙烷
|
82536-56-9
|
Desoximetasone Impurity 24
|
去羥米松雜質(zhì)24
|
916347-23-4
|
Methylprednisolone Hydrogen Succinate EP Impurity F
|
甲潑尼松琥珀酸氫EP雜質(zhì)F
|
2376134-25-5
|
Nintedanib Impurity 67
|
尼達(dá)尼布雜質(zhì)67對照品
|
350-46-9
|
Triamcinolone Acetonide Impurity (Triamcinolone Base)
|
曲安奈德雜質(zhì)(曲安奈德堿)
|
124-94-7
|
Lenalidomide Impurity 17
|
來那度胺雜質(zhì)17
|
90725-68-1
|
Moxifloxacin Impurity 43
|
莫西沙星雜質(zhì)43
|
|
Febuxostat Impurity 72
|
非布司他雜質(zhì)72
|
34133-58-9
|
Desoximetasone Impurity 1 (Beta Methyl 1,2-Dihydro)
|
脫肟酶酮雜質(zhì)1(β-甲基1,2-二氫)
|
|
Ilaprazole Impurity 26
|
艾普拉唑雜質(zhì)26
|
|
Piracetam Impurity 6
|
吡拉西坦雜質(zhì)6
|
2454698-45-2
|
Ilaprazole Impurity 25
|
艾普拉唑雜質(zhì)25
|
|
Brivaracetam Impurity 32
|
布瓦西坦雜質(zhì)32
|
|
Vonoprazan Impurity 103
|
沃諾拉贊雜質(zhì)103
|
13069-02-8
|
Indacaterol Impurity 11
|
茚達(dá)特羅雜質(zhì)11對照品
|
1207760-24-4
|
Budesonide Impurity 13
|
布地奈德雜質(zhì)13
|
2408495-96-3
|
Lacosamide Impurity 21
|
拉科酰胺雜質(zhì)21對照品
|
862372-15-4
|
N-Nitroso Rasagiline-13C3
|
N-亞硝基雷沙吉蘭-12C3對照品
|
2470278-90-9
|
Nintedanib Impurity 40
|
尼達(dá)尼布雜質(zhì)40對照品
|
78466-25-8
|
Hydrocortisone Impurity 32
|
氫化可的松雜質(zhì)32
|
1142365-56-7
|
Moxifloxacin Impurity 88
|
莫西沙星雜質(zhì)88
|
1395471-03-0
|
Esmolol Impurity 15
|
艾司洛爾雜質(zhì)15
|
6452-58-0
|
Betamethasone Impurity 65
|
倍他米松雜質(zhì)65
|
96789-15-0
|
Duloxetine EP Impurity A Maleate (Duloxetine USP Related Compound A Maleate)
|
度洛西汀EP雜質(zhì)A順丁烯二酸鹽(度洛西丁USP相關(guān)化合物A順丁烯酸鹽)
|
116539-60-7
|
Formoterol Impurity 64
|
福莫特羅雜質(zhì)64對照品
|
4125-46-6
|
Brivaracetam Impurity 53
|
布瓦西坦雜質(zhì)53
|
|
Bumetanide Impurity 30
|
布美他尼雜質(zhì)30
|
|
Budesonide Impurity 33
|
布地奈德雜質(zhì)33
|
77017-20-0
|
Fluticasone Impurity 47
|
氟替卡松雜質(zhì)47
|
382631-11-0
|
Fluticasone Impurity 48
|
氟替卡松雜質(zhì)48
|
23961-95-7
|
Landiolol Impurity 29
|
蘭地洛爾雜質(zhì)29
|
67800-61-7
|
(22S)-Budesonide
|
(22S)-布地奈德雜質(zhì)
|
51372-28-2
|
Metoclopramide EP Impurity A (Metoclopramide USP Related Compound A)
|
甲氧氯普胺EP雜質(zhì)A(胃復(fù)安USP相關(guān)化合物A)
|
5608-13-9
|
Fluticasone Furoate EP Impurity J
|
糠酸氟替卡松EP雜質(zhì)J
|
|
Nintedanib Impurity 33 (Intedanib Impurity 33)
|
尼達(dá)尼布雜質(zhì)33(阿達(dá)尼雜質(zhì)33)
|
2380229-45-6
|
Nebivolol Impurity 8 (SR)
|
奈比洛爾雜質(zhì)8(SR)
|
|
Prednisolone Impurity 47
|
潑尼松龍雜質(zhì)47
|
118864-87-2
|
Nintedanib Impurity 1 (Intedanib Impurity 1)
|
尼達(dá)尼布雜質(zhì)1(阿達(dá)尼雜質(zhì)1)
|
2514952-69-1
|
Nintedanib Impurity 57
|
尼達(dá)尼布雜質(zhì)57對照品
|
2102162-78-5
|
Pantoprazole Sulphone N-Oxide
|
泮托拉唑砜氮氧化物
|
953787-55-8
|
Parecoxib Impurity 25
|
帕瑞昔布雜質(zhì)25
|
198470-85-8
|
Loxoprofen Impurity 51
|
洛索洛芬雜質(zhì)51
|
10386-81-9
|
Moxifloxacin Impurity 89
|
莫西沙星雜質(zhì)89
|
128740-13-6
|
Famotidine Impurity 22
|
法莫替丁雜質(zhì)22
|
95853-51-3
|
Vonoprazan Impurity 79
|
沃諾拉贊雜質(zhì)79
|
|
Nintedanib N,N-Dioxide (Intedanib N,N-Dioxide)
|
Nintedanib N,N-二氧化物對照品
|
2734676-68-5
|
Hydrocortisone Impurity 41
|
氫化可的松雜質(zhì)41
|
74050-21-8
|
Betamethasone Impurity 84
|
倍他米松雜質(zhì)84
|
944031-56-5
|
Procaterol Impurity 18 HCl
|
丙卡特羅雜質(zhì)18鹽酸鹽對照品
|
|
Methylprednisolone Impurity 17
|
甲潑尼松雜質(zhì)17
|
7055-53-0
|
Bumetanide Impurity 32
|
布美他尼雜質(zhì)32
|
|
Sorafenib Related Compound 27 HCl
|
索拉非尼相關(guān)化合物 27 鹽酸鹽
|
6144-78-1
|
Dexamethasone Impurity 32
|
地塞米松雜質(zhì)32
|
1169872-15-4
|
Hydrocortisone EP Impurity G (aldehyde form)
|
氫化可的松EP雜質(zhì)G(醛式)
|
14760-49-7
|
Bumetanide Impurity 38
|
布美他尼雜質(zhì)38
|
|
Ilaprazole Impurity 48
|
艾普拉唑雜質(zhì)48
|
|
N-Nitroso Pantoprazole
|
N-硝基泮托拉唑
|
|
Bumetanide Impurity 28
|
布美他尼雜質(zhì)28
|
|
Fluticasone Impurity 59
|
氟替卡松雜質(zhì)59
|
|
Betamethasone Impurity 69
|
倍他米松雜質(zhì)69
|
|
Betamethasone Impurity 95
|
倍他米松雜質(zhì)95
|
|
Ilaprazole Impurity 46
|
艾普拉唑雜質(zhì)46
|
|
Ilaprazole Impurity 58
|
艾普拉唑雜質(zhì)58
|
1508282-92-5
|
N2-Nitroso Moxifloxacin Impurity 81
|
N2亞硝基莫西沙星雜質(zhì)81
|
|
Methylprednisolone Impurity 11
|
甲潑尼松雜質(zhì)11
|
105500-05-8
|
Ilaprazole Impurity 83
|
艾普拉唑雜質(zhì)83
|
2285346-42-9
|
Esmolol Impurity ZY1
|
艾司洛爾雜質(zhì)ZY1
|
116144-60-6
|
Vonoprazan Impurity 108
|
沃諾拉贊雜質(zhì)108
|
|
Vonoprazan Impurity 83
|
沃諾拉贊雜質(zhì)83
|
|
Hydrocortisone Impurity 51
|
氫化可的松雜質(zhì)51
|
|
N-Nitroso Indacaterol Impurity 20
|
N-亞硝基茚達(dá)特羅雜質(zhì)20對照品
|
|
N2-Nitroso Lacosamide
|
N2-亞硝基拉科酰胺對照品
|
|
N-Nitroso Moxifloxacin EP Impurity B
|
N-亞硝基莫西沙星EP雜質(zhì)B
|
|
N6-Nitroso Moxifloxacin Impurity 27
|
N6硝基莫西沙星雜質(zhì)27
|
|
N1-Nitroso Sorafenib
|
N1-亞硝基索拉非尼
|
|
Nintedanib Impurity 51
|
尼達(dá)尼布雜質(zhì)51對照品
|
444667-11-2
|
Triamcinolone Acetonide Impurity (Epoxy Acetonide)
|
曲安奈德雜質(zhì)(環(huán)氧丙酮)
|
|
Desoximetasone Impurity 19
|
去羥米松雜質(zhì)19
|
|
Pantoprazole Impurity ZY1
|
泮托拉唑雜質(zhì)ZY1
|
|
Vonoprazan Impurity 23 Fumarate
|
沃諾拉贊雜質(zhì)23富馬酸鹽
|
|
Metoclopramide Impurity ZY1
|
甲氧氯普胺雜質(zhì)ZY1
|
|